Gene expression profiling as a noninvasive method to monitor for cardiac allograft rejection
BlueCross BlueShield Association
Record ID 32012000757
English
Authors' objectives:
The objective of this Assessment is to determine whether AlloMap® testing improves health outcomes when used as an alternative to other methods of monitoring heart transplant patients for rejection.
Details
Project Status:
Completed
Year Published:
2011
URL for published report:
http://www.bcbs.com/blueresources/tec/vols/26/26_08.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Graft Rejection
- Heart Transplantation
- Monitoring, Physiologic
Contact
Organisation Name:
BlueCross BlueShield Association
Contact Address:
BlueCross BlueShield Association, Technology Evaluation Center, 225 North Michigan Ave, Chicago, Illinois, USA. Tel: 888 832 4321
Contact Name:
tec@bcbsa.com
Contact Email:
tec@bcbsa.com
Copyright:
BlueCross BlueShield Association (BCBS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.